Related Experiment Video
Updated: Aug 6, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose
Alexandre S Quadros1, Rogério Sarmento-Leite, Marcello Bertoluci
1Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology, Dra. Beatriz D'Agord Schaan, Av. Princesa Isabel, 370-Santana, Porto Alegre Cep 90.620-001, Brazil.
Insights
Subtle increases in fasting glucose and insulin resistance are linked to coronary artery disease (CAD). Even slightly elevated glucose levels, not yet diabetes, show a higher prevalence of significant coronary artery stenosis.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Insulin resistance and impaired glucose metabolism are known risk factors for cardiovascular disease.
- The association between subtle glucose metabolism disturbances and CAD requires further elucidation.
Purpose of the Study:
- To investigate the relationship between varying levels of fasting glycemia and insulin resistance with the presence and severity of coronary artery disease.
- To assess if pre-diabetic glucose levels are associated with angiographically confirmed CAD.
Main Methods:
- A cohort of 145 patients undergoing coronary angiography were categorized into four groups based on fasting glucose levels: normal, high-normal, impaired fasting glucose (IFG), and diabetes mellitus (DM).
- Insulin resistance was assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR).
- Coronary artery disease was defined by the presence of ≥30% or ≥70% diameter stenosis in major coronary arteries.
Main Results:
- HOMA-IR values increased progressively across the glucose categories (Normal < High-Normal < IFG < DM; p=0.001).
- The prevalence of CAD, by both stenosis criteria, significantly increased with higher fasting glucose levels (p=0.006 and p=0.03, respectively).
- Patients with impaired fasting glucose showed a higher proportion of CAD compared to those with normal fasting glucose.
Conclusions:
- Subtle disturbances in glucose metabolism, including high-normal fasting glucose and elevated insulin resistance, are significantly associated with angiographically documented coronary artery disease.
- These findings highlight the importance of monitoring glucose metabolism even in individuals without diagnosed diabetes.
- Early identification and management of glucose metabolism abnormalities may be crucial for cardiovascular risk reduction.
Abstract:
This study evaluated the association between progressively higher levels of fasting glycemia (G) and insulin resistance parameters with coronary artery disease (CAD) in patients referred for coronary angiography. All 145 patients (age 58.4+/-0.9 years, 51.7% men) underwent clinical and laboratory evaluation before coronary angiography and subjects were divided into four groups: normal (N, <88 mg/dl), high-normal (H-N, 89-99 mg/dl), impaired fasting glucose (IFG, 100-125 mg/dl) and diabetes (DM, >126 mg/dl or known diabetics). Arteriographic evidence of CAD was determined by two criteria: (1) a 30% or greater diameter stenosis in at least one major coronary artery; (2) a 70% or greater diameter stenosis in at least one major coronary artery. HOMA-IR increased progressively according to each group: N=1.74+/-0.2, H-N=3.14+/-0.3, IFG=4.67+/-0.6 and DM=8.00+/-2.9; p=0.001. The proportion of patients with CAD according to both criteria increased with each G level: CAD criteria 1: N=39.4%, H-N=50%, IFG=60% and DM=69.6%, p=0.006; CAD criteria 2: N=27.3%, H-N=30%, IFG=36% and DM=50%, p=0.03. We demonstrated a significant association between subtle disturbances of the glucose metabolism, assessed by subnormal levels of fasting glucose and insulin resistance parameters, and angiographically documented coronary artery disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Hyperglycemia
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Diabetic Nephropathy
Peripheral Artery Disease I: Introduction
